Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy
- PMID: 33260043
- PMCID: PMC7647441
- DOI: 10.1016/j.thromres.2020.10.038
Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy
Abstract
- •
We report a translational experience of a cardiovascular department facing MACE in COVID-19 patients.
- •
Acute arterial events are the real emergency into this COVID-19 pandemic.
- •
COVID-19 infection may trigger a hypercoagulable status leading to MACE and high mortality rate.
- •
In this COVID-19 outbreak, the adjunct of heparin provides better survival chance independently of the infection-related drug treatment.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Comment on
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32220112 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical